BIO Asia–Taiwan 2021 亞洲生技大會

BIO Asia–Taiwan 2021 亞洲生技大會

講師

Stephen Lee

Session 2 – Pharma-biotech Partnering & Collaboration

Date:21 July (Wednesday)
Time:  12:20 – 13:50 (GMT+8)

Stephen Lee

Director, Early Innovation Partnering, North Asia, Johnson & Johnson Innovation, Asia Pacific
 

Stephen is Director of Early Innovation Partnering, North Asia at Johnson & Johnson Innovation, Asia Pacific.  In this role, he is responsible for the deployment of the Asia Pacific Innovation Center strategy in North Asia by identifying opportunities (in pharmaceuticals, consumer health and medical devices) and building networks within the innovation ecosystem. 

Stephen has over 20 years of experience in the life science sector. Prior to joining Johnson & Johnson, Stephen was the Managing Director of Kybora EM (formerly Torreya EM) where he was responsible for Asia Pacific business development focusing on licensing and M&A advisory services. Stephen is experienced in bringing together investment opportunities and funding.  He has been the founder and CEO of CASiGEN Pharma (a Ventac portfolio company) and BioMatrix Dx. He also served as a partner at Ventac Partners where he played a key role in portfolio company building, strategy, marketing, product analysis and IP development. He has also worked as a consultant for 3V SourceOne Capital, Applied Strategies Consulting, First State Investments, and as a patent examiner for the USPTO. 

Stephen received his D.Phil. in Biochemistry from the University of Oxford, Merton College. He holds an MBA from the University of Chicago Booth School of Business.

Speech title & Synopsis

Accelerating Innovation Through Strategic Partnership

Johnson & Johnson Innovation LLC works across the pharmaceutical, medical device and consumer health sectors to accelerate early-stage, transformational solutions by catalyzing the best ideas, wherever they are in the world. We do this by harnessing our deep scientific capabilities coupled with a wide range of tools, including customized deal structures, company creation, incubation and startup services, capital investments and other innovative business models that aim to meet the diverse needs of entrepreneurs, scientists and emerging companies. Our goal is to help life science and health technology innovations thrive through collaboration and partnership with the global ecosystem, so that together we can change the trajectory of human health. Meet our passionate team of science and technology experts and learn how to collaborate with us at www.jnjinnovation.com.